

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Spaglumic Acid
Therapeutic Area : Ophthalmology
Study Phase : Phase IV
Sponsor : Samil Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : N-Acetyl-Aspartyl-Glutamic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Conjunctivitis, Allergic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 16, 2010
Lead Product(s) : Spaglumic Acid
Therapeutic Area : Ophthalmology
Highest Development Status : Phase IV
Sponsor : Samil Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
